What do you quote as the recurrence risk without radiation for patients that undergo neoadjuvant systemic therapy followed by lumpectomy and are found to have a complete pathologic response?
Patients will frequently ask why they need treatment when there is no cancer left on the pathology specimen.
Perhaps a response referencing the Taiwanese study...